Cargando…

Evaluation of Phytosomal Curcumin as an Anti-inflammatory Agent for Chronic Glial Activation in the GFAP-IL6 Mouse Model

Chronic glial activation is characterized by an increased number of activated microglia and astroglia; these secrete free radicals and cytotoxic cytokines, subsequently causing neuronal damage. This study investigated the hypothesis that a soy-lecithin based phytosomal curcumin formulation can decre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ullah, Faheem, Liang, Huazheng, Niedermayer, Garry, Münch, Gerald, Gyengesi, Erika
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7081170/ https://www.ncbi.nlm.nih.gov/pubmed/32226360 http://dx.doi.org/10.3389/fnins.2020.00170

Ejemplares similares

Effects of a solid lipid curcumin particle formulation on chronic activation of microglia and astroglia in the GFAP-IL6 mouse model
por: Ullah, Faheem, et al.
Publicado: (2020)

Chronic Microglial Activation in the GFAP-IL6 Mouse Contributes to Age-Dependent Cerebellar Volume Loss and Impairment in Motor Function
por: Gyengesi, Erika, et al.
Publicado: (2019)

Spatial Memory and Microglia Activation in a Mouse Model of Chronic Neuroinflammation and the Anti-inflammatory Effects of Apigenin
por: Chesworth, Rose, et al.
Publicado: (2021)

Chronic neuroinflammation during aging leads to cholinergic neurodegeneration in the mouse medial septum
por: Gamage, Rashmi, et al.
Publicado: (2023)

Editorial: Pharmacological approaches towards the resolution of neuroinflammation and neurodegeneration
por: Liang, Huazheng, et al.
Publicado: (2023)

Cholinergic Modulation of Glial Function During Aging and Chronic Neuroinflammation
por: Gamage, Rashmi, et al.
Publicado: (2020)

Curcumin and Apigenin – novel and promising therapeutics against chronic neuroinflammation in Alzheimer's disease
por: Venigalla, Madhuri, et al.
Publicado: (2015)

Evaluation of eGFP expression in the ChAT-eGFP transgenic mouse brain
por: Gamage, Rashmi, et al.
Publicado: (2023)

Plant polyphenols as inhibitors of NF-κB induced cytokine production—a potential anti-inflammatory treatment for Alzheimer's disease?
por: Karunaweera, Niloo, et al.
Publicado: (2015)

Chemopreventive Effect of Phytosomal Curcumin on Hepatitis B Virus-Related Hepatocellular Carcinoma in A Transgenic Mouse Model
por: Teng, Chiao-Fang, et al.
Publicado: (2019)

Editorial: Neuronal Pathways Affecting Glial Function
por: Buskila, Yossi, et al.
Publicado: (2021)

The role of gigaxonin in the degradation of the glial-specific intermediate filament protein GFAP
por: Lin, Ni-Hsuan, et al.
Publicado: (2016)

Discrepancy in the Usage of GFAP as a Marker of Satellite Glial Cell Reactivity
por: Mohr, Kjeld Morten, et al.
Publicado: (2021)

Blood Levels of Glial Fibrillary Acidic Protein (GFAP) in Patients with Neurological Diseases
por: Mayer, Christoph A., et al.
Publicado: (2013)

Glial Fibrillary Acidic Protein (GFAP): Neuroinflammation Biomarker in Acute Ischemic Stroke
por: Amalia, Lisda
Publicado: (2021)

A case of glial fibrillary acidotic protein (GFAP) meningoencephalitis with rheumatoid arthritis
por: Salari, Mehri, et al.
Publicado: (2023)

Phytosome drug delivery system for natural cosmeceutical compounds: Whitening agent and skin antioxidant agent
por: Susilawati, Yasmiwar, et al.
Publicado: (2021)

Protective Effects of Curcumin and its Nano-Phytosome on Carrageenan-Induced Inflammation in Mice Model: Behavioral and Biochemical Responses
por: Baradaran, Saeideh, et al.
Publicado: (2020)

Greenselect Phytosome for Borderline Metabolic Syndrome
por: Belcaro, Gianni, et al.
Publicado: (2013)

Radiographic evolution of myelitis in a case of glial fibrillary acidic protein (GFAP) astrocytopathy
por: Goyne, Christopher E, et al.
Publicado: (2023)

Development of an ultrasensitive microfluidic assay for the analysis of Glial fibrillary acidic protein (GFAP) in blood
por: Fazeli, Badrieh, et al.
Publicado: (2023)

Nanoscale Phytosomes as an Emerging Modality for Cancer Therapy
por: Kadriya, Ahmad, et al.
Publicado: (2023)

Chronic psychosocial stress and citalopram modulate the expression of the glial proteins GFAP and NDRG2 in the hippocampus
por: Araya-Callís, Carolina, et al.
Publicado: (2012)

Glial Fibrillary Acidic Protein (GFAP) Astrocytopathy Presenting as Mild Encephalopathy with Reversible Splenium Lesion
por: Héraud, Charlotte, et al.
Publicado: (2021)

Association of plasma glial fibrillary acidic protein (GFAP) with neuroimaging of Alzheimer's disease and vascular pathology
por: Shir, Dror, et al.
Publicado: (2022)

GFAP and desmin expression in lymphatic tissues leads to difficulties in distinguishing between glial and stromal cells
por: Günther, Hauke Simon, et al.
Publicado: (2021)

GFAP-directed Inactivation of Men1 Exploits Glial Cell Plasticity in Favor of Neuroendocrine Reprogramming
por: Duan, Suzann, et al.
Publicado: (2022)

Characterisation of GFAP-Expressing Glial Cells in the Dorsal Root Ganglion after Spared Nerve Injury
por: Konnova, Elena A., et al.
Publicado: (2023)

Prenatal ethanol exposure impairs the formation of radial glial fibers and promotes the transformation of GFAPδ-positive radial glial cells into astrocytes
por: Li, Yu, et al.
Publicado: (2021)

Safety and efficacy of an add-on therapy with curcumin phytosome and piperine and/or lipoic acid in subjects with a diagnosis of peripheral neuropathy treated with dexibuprofen
por: Di Pierro, Francesco, et al.
Publicado: (2013)

The effects of phytosomal curcumin supplementation on clinical symptoms, and inflammatory and oxidative stress biomarkers in patients with migraine: A protocol for a randomized double-blind placebo-controlled trial
por: Shojaei, Mehrnaz, et al.
Publicado: (2023)

Regulatory mechanisms for 3′-end alternative splicing and polyadenylation of the Glial Fibrillary Acidic Protein, GFAP, transcript
por: Blechingberg, Jenny, et al.
Publicado: (2007)

Reductions in hypothalamic Gfap expression, glial cells and α-tanycytes in lean and hypermetabolic Gnasxl-deficient mice
por: Holmes, Andrew P., et al.
Publicado: (2016)

Expression of radial glial markers (GFAP, BLBP and GS) during telencephalic development in the catshark (Scyliorhinus canicula)
por: Docampo-Seara, A., et al.
Publicado: (2018)

Safety and efficacy of an add-on therapy with curcumin phytosome and piperine and/or lipoic acid in subjects with a diagnosis of peripheral neuropathy treated with dexibuprofen [Erratum]
Publicado: (2013)

GFAP at 50
por: Messing, Albee, et al.
Publicado: (2020)

Therapeutic Opportunities for Food Supplements in Neurodegenerative Disease and Depression
por: Businaro, Rita, et al.
Publicado: (2021)

From the Bush to the Brain: Preclinical Stages of Ethnobotanical Anti-Inflammatory and Neuroprotective Drug Discovery—An Australian Example
por: Kumar, Payaal, et al.
Publicado: (2023)

Author Correction: GFAP and desmin expression in lymphatic tissues leads to difficulties in distinguishing between glial and stromal cells
por: Günther, Hauke Simon, et al.
Publicado: (2021)

Supratentorial hydrocephalus with an anti‐glial fibrillary acidic protein (GFAP) antibody‐positive status: A case report
por: Tang, Lei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rljuic79u2cmj4ajp9htfnr880